Molecular Characterization and Correlation with β-lactam Resistance of Streptococcus pneumonia Isolates in Hangzhou, China

被引:1
作者
Chu Mei Fen [1 ]
Liu Xiao Xiang [2 ]
Zhang Shao Ni [2 ,3 ]
Huang Yan Ying [2 ,3 ]
Du Peng [2 ]
Wang Li Fang [2 ]
Ji Lei [2 ]
Yan Jie [4 ,5 ]
Sun Ai Hua [2 ]
机构
[1] Hangzhou Med Coll, Dept Lab Med, Hangzhou 310053, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Fac Basic Med, Hangzhou 310053, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Sch Lab Med Sci & Life Sci, Wenzhou 325035, Zhejiang, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Div Basic Med Microbiol, Hangzhou 310003, Zhejiang, Peoples R China
[5] Zhejiang Univ, Coll Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China
关键词
PENICILLIN-BINDING PROTEINS; ANTIMICROBIAL SUSCEPTIBILITY; PREVALENCE; DOMAINS;
D O I
10.3967/bes2018.050
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Penicillin-binding proteins (PBPs) are the target of beta-lactam antibiotics (the major treatment for Streptococcus pneumoniae infections), and mutations in PBPs are considered as a primary mechanism for the development of beta-lactam resistance in S. pneumoniae. This study was conducted to investigate the mutations in the PBPs of clinical S. pneumoniae isolates in Hangzhou, China, in correlation with beta-lactam resistance. Results showed that 19F was the predominant serotype (7/27) and 14 of the S. pneumoniae isolates were resistant to both penicillin G and cephalosporin. Genotyping results suggested that beta-lactam-resistant isolates primarily exhibited single-site mutations in both the STMK and SRNVP motifs of pbp1 alpha in combination with double-site mutations in the STMK motif of pbp2x, which might be the primary mechanisms underlying the beta-lactam resistance of the isolates in this study.
引用
收藏
页码:389 / +
页数:40
相关论文
共 12 条
[1]  
Breakpoints C, 2011, M100S21 CLSI
[2]   Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of β-lactam resistance [J].
Chesnel, L ;
Carapito, R ;
Croizé, J ;
Dideberg, O ;
Vernet, T ;
Zapun, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2895-2902
[3]   Activity of doripenem and comparator β-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x [J].
Davies, Todd A. ;
Shang, Wenchi ;
Bush, Karen ;
Flamm, Robert K. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) :751-753
[4]   A Low-Affinity Penicillin-Binding Protein 2x Variant Is Required for Heteroresistance in Streptococcus pneumoniae [J].
Engel, Hansjuerg ;
Mika, Moana ;
Denapaite, Dalia ;
Hakenbeck, Regine ;
Muehlemann, Kathrin ;
Heller, Manfred ;
Hathaway, Lucy J. ;
Hilty, Markus .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) :3934-3941
[5]   Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations [J].
Hackel, M. ;
Lascols, C. ;
Bouchillon, S. ;
Hilton, B. ;
Morgenstern, D. ;
Purdy, J. .
VACCINE, 2013, 31 (42) :4881-4887
[6]   Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013 [J].
Huang, Songyin ;
Liu, Xiaoqiang ;
Lao, Weisi ;
Zeng, Suhua ;
Liang, Huiqi ;
Zhong, Rihui ;
Dai, Xinlu ;
Wu, Xiquan ;
Li, Hongyu ;
Yao, Yandan .
BMC INFECTIOUS DISEASES, 2015, 15
[7]   Active site restructuring regulates ligand recognition in class A penicillin-binding proteins [J].
Macheboeuf, P ;
Di Guilmi, AM ;
Job, V ;
Vernet, T ;
Dideberg, O ;
Dessen, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :577-582
[8]   High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study) [J].
Song, JH ;
Jung, SI ;
Ko, KS ;
Kim, NY ;
Son, JS ;
Chang, HH ;
Ki, HK ;
Oh, WS ;
Suh, JY ;
Peck, KR ;
Lee, NY ;
Yang, YH ;
Lu, Q ;
Chongthaleong, A ;
Chiu, CH ;
Lalitha, MK ;
Perera, J ;
Yee, TT ;
Kumarasinghe, G ;
Jamal, F ;
Kamarulzaman, A ;
Parasakthi, N ;
Van, PH ;
Carlos, C ;
So, T ;
Ng, TK ;
Shibl, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2101-2107
[9]   Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18 [J].
Su, Lin-Hui ;
Wu, Tsu-Lan ;
Kuo, An-Jing ;
Chia, Ju-Hsin ;
Chiu, Cheng-Hsun .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) :336-342
[10]   Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumoniae isolated from Shanghai, China [J].
Yang, Fan ;
Xu, Xiao-Gang ;
Yang, Min-Jie ;
Zhang, Ying-Yuan ;
Klugman, Keith P. ;
McGee, Lesley .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (05) :386-391